Swedish Orphan Biovitrum Agrees with Fresenius Biotech GmbH to Distribute Removab(R)
1/27/2011 8:48:46 AM
More...
|
Nabi Biopharmaceuticals (NABI) Acquires Exclusive North American Commercialization Rights To Phase III Antibody Product For Prevention And Treatment Of Rejection Following Organ Transplantation
4/3/2006 4:35:34 PM
More...
|
Enzon Pharmaceuticals, Inc. (ENZN) Returns Rights To Transplantation Product To Fresenius Biotech GmbH
1/6/2006 11:49:06 AM
More...
|
Xcyte Therapies And Fresenius Biotech GmbH Enter HIV Gene Therapy Collaboration
10/19/2005 5:09:42 PM
More...
|